Athyrium Opportunities Fund (a) Lp - Net Worth and Insider Trading

Athyrium Opportunities Fund (a) Lp Net Worth

The estimated net worth of Athyrium Opportunities Fund (a) Lp is at least $1 Million dollars as of 2024-06-21. Athyrium Opportunities Fund (a) Lp is the 10% Owner of Biora Therapeutics Inc and owns about 1,455,876 shares of Biora Therapeutics Inc (BIOR) stock worth over $1 Million. Details can be seen in Athyrium Opportunities Fund (a) Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Athyrium Opportunities Fund (a) Lp has not made any transactions after 2021-06-14 and currently still holds the listed stock(s).

Transaction Summary of Athyrium Opportunities Fund (a) Lp

To

Athyrium Opportunities Fund (a) Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Athyrium Opportunities Fund (a) Lp owns 1 companies in total, including Biora Therapeutics Inc (BIOR) .

Click here to see the complete history of Athyrium Opportunities Fund (a) Lp’s form 4 insider trades.

Insider Ownership Summary of Athyrium Opportunities Fund (a) Lp

Ticker Comapny Transaction Date Type of Owner
BIOR Biora Therapeutics Inc 2021-06-14 10 percent owner

Athyrium Opportunities Fund (a) Lp Latest Holdings Summary

Athyrium Opportunities Fund (a) Lp currently owns a total of 1 stock. Athyrium Opportunities Fund (a) Lp owns 1,455,876 shares of Biora Therapeutics Inc (BIOR) as of June 14, 2021, with a value of $1 Million.

Latest Holdings of Athyrium Opportunities Fund (a) Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BIOR Biora Therapeutics Inc 2021-06-14 1,455,876 0.70 1,018,968

Holding Weightings of Athyrium Opportunities Fund (a) Lp


Athyrium Opportunities Fund (a) Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Athyrium Opportunities Fund (a) Lp has made a total of 3 transactions in Biora Therapeutics Inc (BIOR) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Biora Therapeutics Inc is the acquisition of 323,887 shares on June 14, 2021, which cost Athyrium Opportunities Fund (a) Lp around $20 Million.

Insider Trading History of Athyrium Opportunities Fund (a) Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Athyrium Opportunities Fund (a) Lp Trading Performance

GuruFocus tracks the stock performance after each of Athyrium Opportunities Fund (a) Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Athyrium Opportunities Fund (a) Lp is -25.58%. GuruFocus also compares Athyrium Opportunities Fund (a) Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Athyrium Opportunities Fund (a) Lp within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Athyrium Opportunities Fund (a) Lp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Athyrium Opportunities Fund (a) Lp

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.33 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 9.28 LIMIT LIMIT LIMIT LIMIT LIMIT

Athyrium Opportunities Fund (a) Lp Ownership Network

Ownership Network List of Athyrium Opportunities Fund (a) Lp

No Data

Ownership Network Relation of Athyrium Opportunities Fund (a) Lp

Insider Network Chart

Athyrium Opportunities Fund (a) Lp Owned Company Details

What does Biora Therapeutics Inc do?

Who are the key executives at Biora Therapeutics Inc?

Athyrium Opportunities Fund (a) Lp is the 10 percent owner of Biora Therapeutics Inc. Other key executives at Biora Therapeutics Inc include 10 percent owner Athyrium Opportunities Iii Co-invest 1 Lp , director & Chief Executive Officer Aditya P. Mohanty , and 10 percent owner Athyrium Capital Management, Lp .

Biora Therapeutics Inc (BIOR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biora Therapeutics Inc (BIOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biora Therapeutics Inc (BIOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biora Therapeutics Inc (BIOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biora Therapeutics Inc Insider Transactions

No Available Data

Athyrium Opportunities Fund (a) Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Athyrium Opportunities Fund (a) Lp. You might contact Athyrium Opportunities Fund (a) Lp via mailing address: 605 Third Avenue, 22nd Floor, New York Ny 10158.

Discussions on Athyrium Opportunities Fund (a) Lp

No discussions yet.